Otros idiomas Gossamer Bio, Inc.

Acciones

GOSS

US38341P1021

Biotecnología e investigación médica

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 18/07/2025			Variación 5 días	Varia. 1 de enero.
1,700 ^USD	-0,58 %		+25,00 %	+87,93 %

14/07	GOSSAMER BIO, INC. : Obtiene una recomendación de compra de Scotiabank	ZM
16/06	Gossamer Bio anuncia la finalización de la inscripción en el estudio PROSERA de fase III para el registro de un tratamiento contra la HAP	RE

Otros idiomas

Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000 Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2000 Dynamic Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Small Cap Comp Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000E Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Microcap Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000 Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Microcap Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2500 Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Small Cap Completeness Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2000 Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000E Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2000 Growth Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2500 Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2500 Growth Benchmark	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000 Growth Benchmark	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Small Cap Comp Growth Benchmark	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 3000E Growth Benchmark	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell Microcap Growth Benchmark Index	30/06
Gossamer Bio, Inc.(NasdaqGS:GOSS) added to Russell 2000 Growth Benchmark	30/06
Gossamer Bio Announces Completion Of Enrollment In Registrational Phase 3 PROSERA Study For The Treatment Of PAH	16/06
Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH	16/06
Gossamer Bio, Inc. Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH	16/06
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule	06/06
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	06/06
Gossamer Bio : May 2025 Corporate Presentation (3b1faa)	15/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Gossamer Bio, Inc.

Acciones

GOSS

US38341P1021

Biotecnología e investigación médica

Otros idiomas

Filtros